کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8737642 | 1591367 | 2018 | 7 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Transcriptomic studies in tolerance: Lessons learned and the path forward
ترجمه فارسی عنوان
مطالعات ترنسکتکتومی در تحمل: درس های آموخته شده و راه پیش رو
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
GEPSRLTregsNGSPPVTACDHSCregulatory T-cells - T-cell های نظارتیpositive predictive value - ارزش پیش بینی مثبتnegative predictive value - ارزش پیش بینی منفیMolecular biomarkers - بیومارکرهای مولکولیTacrolimus - تاکرولیموسLinear discriminant analysis - تجزیه و تحلیل خطی خطیLDA - تخصیص پنهان دیریکلهTolerance - تلرانس Next generation sequencing - توالی نسل بعدیSirolimus - سیرولیموس، راپامایسینMHC - مجموعه سازگاری بافتی اصلیmajor histocompatibility complex - مجموعه سازگاری بافتی اصلیNPV یا negative predictive value - مقادیر پیش بینی شده منفیGene expression profile - پروفایل بیان ژنClinical transplantation - پیوند بالینیRenal transplant - پیوند کلیه
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
چکیده انگلیسی
Immunosuppression after solid organ transplantation is a delicate balance of the immune response and is a complex phenomenon with many factors involved. Despite advances in the care of patients receiving organ transplants the adverse effects associated with immunosuppressive agents and the risks of long-term immunosuppression present a series of challenges and the need to weigh the risks and benefits of either over or under-immunosuppression. Ideally, if all transplant recipients could develop donor-specific immunological tolerance, it could drastically improve long-term graft survival without the need for immunosuppressive agents. In the absence of this ideal situation, the next best approach would be to develop tools to determine the adequacy of immunosuppression in each patient, in a manner that would individualize or personalize therapy. Despite current genomics-based studies of tolerance biomarkers in transplantation there are currently, no clinically validated tools to safely increase or decrease the level of IS that is beneficial to the patient. However, the successful identification of biomarkers and/or mechanisms of tolerance that have implications on long-term graft survival and outcomes depend on proper integration of study design, experimental protocols, and data-driven hypotheses. The objective of this article is to first, discuss the progress made on genomic biomarkers of immunological tolerance and the future avenues for the development of such biomarkers specifically in kidney transplantation. Secondly, we provide a set of guiding principles and identify the pitfalls, advantages, and drawbacks of studies that generate genomic data aimed at understanding transplant tolerance that is applicable to all solid transplants.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Human Immunology - Volume 79, Issue 5, May 2018, Pages 395-401
Journal: Human Immunology - Volume 79, Issue 5, May 2018, Pages 395-401
نویسندگان
Sunil M. Kurian, Thomas C. Whisenant, James M. Mathew, Joshua Miller, Joseph R. Leventhal,